Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
0.8053
-0.0247 (-2.98%)
At close: Sep 16, 2026, 4:00 PM EDT
0.8001
-0.0052 (-0.65%)
After-hours: Sep 16, 2026, 5:24 PM EDT
Invivyd Employees
Invivyd had 122 employees as of December 31, 2025. The number of employees increased by 22 or 22.00% compared to the previous year.
Employees
122
Change (1Y)
22
Growth (1Y)
22.00%
Revenue / Employee
$478,402
Profits / Employee
-$879,779
Market Cap
237.37M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 122 | 22 | 22.00% | 122 | 0 |
| Dec 31, 2024 | 100 | 5 | 5.26% | 99 | 1 |
| Dec 31, 2023 | 95 | 9 | 10.47% | 94 | 1 |
| Dec 31, 2022 | 86 | -17 | -16.50% | 84 | 2 |
| Dec 31, 2021 | 103 | - | - | 101 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Bicycle Therapeutics | 288 |
| ProQR Therapeutics | 187 |
| Lyell Immunopharma | 161 |
| Entrada Therapeutics | 152 |
| AC Immune | 122 |
| Foghorn Therapeutics | 106 |
| Lineage Cell Therapeutics | 77 |
IVVD News
- 2 days ago - Invivyd Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 7 days ago - Invivyd management to meet virtually with BTIG - TheFly
- 8 days ago - Invivyd to Participate in Upcoming September Investor Conferences - GlobeNewsWire
- 13 days ago - Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 15 days ago - Cantor says Invivyd should be trading ‘meaningfully higher’ after update - TheFly
- 15 days ago - Invivyd appoints Marc Elia as CEO - TheFly
- 15 days ago - Invivyd provides update on VYD2311 program, DECLARATION study - TheFly
- 15 days ago - Invivyd Appoints Chairman Marc W. Elia as Chief Executive Officer; Approaches Results of VYD2311 studies DECLARATION and LIBERTY - GlobeNewsWire